Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Annals of the Rheumatic Diseases 1995;54:49-52; doi:10.1136/ard.54.1.49
Copyright © 1995 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, C
Right arrow Articles by Mitchell, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, C
Right arrow Articles by Mitchell, M

Rheumatoid arthritis, corticosteroid therapy and hip fracture.

C Cooper , C Coupland , M Mitchell

MRC Environmental Epidemiology Unit, Southampton General Hospital, United Kingdom.

OBJECTIVE--To identify the risk of hip fracture in patients with rheumatoid arthritis and those taking corticosteroids. METHODS--In a population based case-control study, we compared 300 consecutive patients with hip fracture aged 50 years and over from a defined district and 600 age and sex matched community controls. RESULTS--The risk of hip fracture was increased in patients with rheumatoid arthritis (odds ratio (OR) 2.1; 95% confidence interval (CI) 1.0 to 4.7) and those receiving corticosteroids (OR 2.7; 95% CI 1.2 to 5.8). The risk attributable to rheumatoid arthritis was markedly reduced by adjusting for functional impairment, while that for steroid use remained after adjusting for body mass index, smoking, alcohol, and functional status. CONCLUSIONS--Hip fracture risk is approximately doubled amongst patients with rheumatoid arthritis and among those taking steroids. These risk increases are, to some extent, independent of each other. In rheumatoid arthritis, the risk was most closely associated with functional impairment, whereas steroid use did not appear to be confounded by this variable.





This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M Guler-Yuksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, H M J Hulsmans, W M de Beus, K H Han, F C Breedveld, B A C Dijkmans, C F Allaart, et al.
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis
Ann Rheum Dis, June 1, 2008; 67(6): 823 - 828.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M Guler-Yuksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, F C Breedveld, C F Allaart, J K de Vries-Bouwstra, B A C Dijkmans, W F Lems, H K Ronday, A J Peeters, et al.
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis
Ann Rheum Dis, November 1, 2007; 66(11): 1508 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Saviola, L. Abdi. Ali, S. Shams. Eddin, A. Coppini, F. Cavalieri, L. Campostrini, S. Sacco, M. Bucci, G. Cirino, and M. Rossini
Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study
Rheumatology, June 1, 2007; 46(6): 994 - 998.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. P. van Staa, P. Geusens, B. Zhang, H. G. M. Leufkens, A. Boonen, and C. Cooper
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
Rheumatology, March 1, 2007; 46(3): 460 - 466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.I. Syed, N.A. Patel, S. Jan, A. Shaikh, B. Grunden, and K. Morar
Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis.
AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 1938 - 1943.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
B. T. Summey and G. Yosipovitch
Glucocorticoid-Induced Bone Loss in Dermatologic Patients: An Update
Arch Dermatol, January 1, 2006; 142(1): 82 - 90.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Armstrong, C M Swarbrick, S R Pye, and T W O'Neill
Occurrence and risk factors for falls in rheumatoid arthritis
Ann Rheum Dis, November 1, 2005; 64(11): 1602 - 1604.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
A. Bhattacharya, M. Rahman, J. Banu, R. A. Lawrence, H. S. McGuff, I.R. Garrett, M. Fischbach, and G. Fernandes
Inhibition of Osteoporosis in Autoimmune Disease Prone MRL/Mpj-Faslpr Mice by N-3 Fatty Acids
J. Am. Coll. Nutr., June 1, 2005; 24(3): 200 - 209.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
T.-P. van Staa, P. Geusens, H.A.P. Pols, C. de Laet, H.G.M. Leufkens, and C. Cooper
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
QJM, March 1, 2005; 98(3): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M C Lodder, Z de Jong, P J Kostense, E T H Molenaar, K Staal, A E Voskuyl, J M W Hazes, B A C Dijkmans, and W F Lems
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density
Ann Rheum Dis, December 1, 2004; 63(12): 1576 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. Kaz Kaz, D. Johnson, S. Kerry, U. Chinappen, K. Tweed, and S. Patel
Fall-related risk factors and osteoporosis in women with rheumatoid arthritis
Rheumatology, October 1, 2004; 43(10): 1267 - 1271.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Gluck and G. Colice
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Chest, May 1, 2004; 125(5): 1859 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
R E Orstavik, G Haugeberg, T Uhlig, P Mowinckel, J A Falch, J I Halse, and T K Kvien
Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables
Ann Rheum Dis, February 1, 2004; 63(2): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J W J Bijlsma, M Boers, K G Saag, and D E Furst
Glucocorticoids in the treatment of early and late RA
Ann Rheum Dis, November 1, 2003; 62(11): 1033 - 1037.
[Full Text] [PDF]


Home page
QJMHome page
N. Porter, H.L. Beynon, and H.S. Randeva
Endocrine and reproductive manifestations of sarcoidosis
QJM, August 1, 2003; 96(8): 553 - 561.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. D. Ringe, A. Dorst, H. Faber, K. Ibach, and J. Preuss
Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis
Rheumatology, June 1, 2003; 42(6): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
I W Chantler, M W J Davie, S F Evans, and J S Rees
Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service
Ann Rheum Dis, April 1, 2003; 62(4): 350 - 352.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. Hirayama, L. Danks, A. Sabokbar, and N. A. Athanasou
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis
Rheumatology, November 1, 2002; 41(11): 1232 - 1239.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. S. Yeap and D. J. Hosking
Management of corticosteroid-induced osteoporosis
Rheumatology, October 1, 2002; 41(10): 1088 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S P Tuck and R M Francis
Osteoporosis
Postgrad. Med. J., September 1, 2002; 78(923): 526 - 532.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J M Nolla, J Fiter, C Gomez-Vaquero, J J Alegre, J Valverde, and D Roig-Escofet
Value of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry
Ann Rheum Dis, August 1, 2001; 60(8): 799 - 801.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. A. Yood, L. R. Harrold, L. Fish, J. Cernieux, S. Emani, E. Conboy, and J. H. Gurwitz
Prevention of Glucocorticoid-Induced Osteoporosis: Experience in a Managed Care Setting
Arch Intern Med, May 28, 2001; 161(10): 1322 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
T M Huusko, M Korpela, P Karppi, V Avikainen, H Kautiainen, and R Sulkava
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
Ann Rheum Dis, May 1, 2001; 60(5): 521 - 522.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
L J Walsh, C A Wong, J Oborne, S Cooper, S A Lewis, M Pringle, R Hubbard, and A E Tattersfield
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease
Thorax, April 1, 2001; 56(4): 279 - 284.
[Abstract] [Full Text]


Home page
LupusHome page
D Sen and R W Keen
Osteoporosis in systemic lupus erythematosus: prevention and treatment
Lupus, March 1, 2001; 10(3): 227 - 232.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
T. P. van Staa, H. G. M. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
Rheumatology, December 1, 2000; 39(12): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
R.M. Francis, S.P. Baillie, A.J. Chuck, P.R. Crook, T. Daymond, N. Dunn, J.N. Fordham, C. Kelly, and A. Rodgers
Management of osteoporosis in patients with hip fractures
QJM, August 1, 2000; 93(8): 501 - 506.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Conron, C. Young, and H. L. C. Beynon
Calcium metabolism in sarcoidosis and its clinical implications
Rheumatology, July 1, 2000; 39(7): 707 - 713.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J M NOLLA, C GÓMEZ-VAQUERO, J FITER, and D ROIG-ESCOFET
Computed digital absorptiometry of the hand: screening method of bone loss in postmenopausal women with RA
Ann Rheum Dis, June 1, 2000; 59(6): 490b - 490.
[Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M E LLOYD, T D SPECTOR, and R HOWARD
Osteoporosis in neurological disorders
J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 543 - 547.
[Full Text]


Home page
Rheumatology (Oxford)Home page
A. Struijs, A. Smals, S. A. de Witte, W. H. L. Hackeng, and H. Mulder
Acute effects of etidronate on glucocorticoid-induced bone degradation
Rheumatology, May 1, 2000; 39(5): 523 - 529.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
T.P. van Staa, H.G.M. Leufkens, L. Abenhaim, B. Begaud, B. Zhang, and C. Cooper
Use of oral corticosteroids in the United Kingdom
QJM, February 1, 2000; 93(2): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
I. R. Reid
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
J Intensive Care Med, September 1, 1999; 14(5): 231 - 242.
[PDF]


Home page
GutHome page
J E COMPSTON
Management of bone disease in patients on long term glucocorticoid therapy
Gut, June 1, 1999; 44(6): 770 - 772.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
P. Geusens, J. Dequeker, J. Vanhoof, R. Stalmans, S. Boonen, J. Joly, J. Nijs, and J. Raus
Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study
Ann Rheum Dis, December 1, 1998; 57(12): 724 - 727.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
W F LEMS and B A C DIJKMANS
Should we look for osteoporosis in patients with rheumatoid arthritis?
Ann Rheum Dis, June 1, 1998; 57(6): 325 - 327.
[Full Text]


Home page
ThoraxHome page
S. COWAN, S. MORIN, and P. ERNST
Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases
Thorax, May 1, 1998; 53(5): 331 - 332.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Roux, P. Oriente, R. Laan, R. A. Hughes, J. Ittner, S. Goemaere, O. Di Munno, J. M. Pouillès, S. Horlait, and B. Cortet
Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1128 - 1133.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
J. W J BIJLSMA
Prevention of glucocorticoid induced osteoporosis
Ann Rheum Dis, September 1, 1997; 56(9): 507 - 509.
[Full Text]


Home page
BMJHome page
C. Olesen, H. T. Sorensen, F. H. Steffensen, G. L. Nielsen, and J. Olsen
Danish data confirm low prevalence of HRT among women prescribed oral corticosteroids
BMJ, November 16, 1996; 313(7067): 1264 - 1264.
[Full Text]


Home page
DTBHome page
Corticosteroid-induced osteoporosis
DTB, November 1, 1996; 34(11): 84 - 86.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
L J Walsh, C A Wong, M Pringle, and A E Tattersfield
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study
BMJ, August 10, 1996; 313(7053): 344 - 346.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1995 BMJ Publishing Group Ltd & European League Against Rheumatism